Lifestyle change help for GLP-1 users
Part of Hormones & metabolism clinical trials.
This study tests a 4-month digital program to help people taking a GLP-1 medication (like Ozempic or Wegovy) make healthy lifestyle changes while they continue the drug. Participants will get guidance and wear a Fitbit to track activity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Started a GLP-1 medication in the last 6 months
- Currently taking a GLP-1 and plan to keep taking it
- Body mass index (BMI) of 27 or higher
- Able to speak and read English or Spanish
- Willing to join a 4-month online lifestyle program and wear a Fitbit for 8 months
- Not already in a structured weight loss or exercise program, and not pregnant or planning pregnancy in the next year
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a 6-month behavioral program (including exercise, diet, and mindfulness) designed to help you keep weight off after stopping GLP-1 or similar weight-loss medications. It's for people who have already lost at least 15% of their body weight and stopped or are stopping these medications.
This study tests whether a daily supplement can help fill nutrient gaps and improve gut health for people who are already taking GLP-1 weight-loss medications (like Ozempic or Wegovy). Participants must be on a stable dose for at least 8 weeks and be generally healthy without other chronic conditions.
This study tests whether a GLP-1 medication (like Ozempic) can help people with obesity who are having hip or knee replacement surgery. It aims to see if the medication improves recovery and outcomes.
This study tests whether taking a special multivitamin and probiotic can improve gut health in people who are already taking a GLP-1 medication. It lasts about 12 weeks and involves taking the supplements daily.
This study tests whether a 12-week program of exercise and personalized nutrition counseling can help obese adults maintain muscle and bone while taking GLP-1 medications (drugs that help with weight loss). GLP-1 drugs can sometimes cause muscle loss, so this trial explores whether targeted exercise and nutrition can prevent that.
This study follows people who recently stopped taking a GLP-1 medication (like Wegovy or Ozempic) to understand how weight, eating habits, and daily routines change over time. It aims to help patients and doctors know what to expect after stopping the drug.
Hear when a new GLP-1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.